Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2011; 6(1): e16447.
Published online Jan 27, 2011. doi:  10.1371/journal.pone.0016447
PMCID: PMC3029367

Induction of the Wnt Antagonist Dickkopf-1 Is Involved in Stress-Induced Hippocampal Damage

Sergio Ferreira, Editor

Abstract

The identification of mechanisms that mediate stress-induced hippocampal damage may shed new light into the pathophysiology of depressive disorders and provide new targets for therapeutic intervention. We focused on the secreted glycoprotein Dickkopf-1 (Dkk-1), an inhibitor of the canonical Wnt pathway, involved in neurodegeneration. Mice exposed to mild restraint stress showed increased hippocampal levels of Dkk-1 and reduced expression of β-catenin, an intracellular protein positively regulated by the canonical Wnt signalling pathway. In adrenalectomized mice, Dkk-1 was induced by corticosterone injection, but not by exposure to stress. Corticosterone also induced Dkk-1 in mouse organotypic hippocampal cultures and primary cultures of hippocampal neurons and, at least in the latter model, the action of corticosterone was reversed by the type-2 glucocorticoid receptor antagonist mifepristone. To examine whether induction of Dkk-1 was causally related to stress-induced hippocampal damage, we used doubleridge mice, which are characterized by a defective induction of Dkk-1. As compared to control mice, doubleridge mice showed a paradoxical increase in basal hippocampal Dkk-1 levels, but no Dkk-1 induction in response to stress. In contrast, stress reduced Dkk-1 levels in doubleridge mice. In control mice, chronic stress induced a reduction in hippocampal volume associated with neuronal loss and dendritic atrophy in the CA1 region, and a reduced neurogenesis in the dentate gyrus. Doubleridge mice were resistant to the detrimental effect of chronic stress and, instead, responded to stress with increases in dendritic arborisation and neurogenesis. Thus, the outcome of chronic stress was tightly related to changes in Dkk-1 expression in the hippocampus. These data indicate that induction of Dkk-1 is causally related to stress-induced hippocampal damage and provide the first evidence that Dkk-1 expression is regulated by corticosteroids in the central nervous system. Drugs that rescue the canonical Wnt pathway may attenuate hippocampal damage in major depression and other stress-related disorders.

Introduction

Abnormalities in mechanisms of resilience to stress are implicated in the pathophysiology of major depressive disorders [1]. Severe depression or depression associated with psychotic symptoms is associated with hypercortisolemia [2], which reflects an impaired negative feed-back of glucocorticoids on the activity of the hypothalamic-pituitary-adrenal (HPA) axis [3], an enhanced adrenal response to adrenocorticotropic hormone (ACTH) [4], or other mechanisms. Excess of glucocorticoids triggers a series of pathological events that may be involved in the pathophysiology of hippocampal atrophy in depressed patients [5][7]. Chronic stress or exogenous glucocorticoids reduce dendritic arborisation in hippocampal neurons [8][14] and can also cause hippocampal neuronal death [15][17]. In addition, chronic stress reduces neurogenesis in the hippocampal dentate gyrus [1], an event that further links HPA hyperactivity to hippocampal atrophy. Understanding the mechanisms that underlie hippocampal damage in response to stress/glucocorticoids may shed new lights into the pathophysiology of mood disorders and stress-related cognitive dysfunctions, and may lead to the identification of new therapeutic targets. Glucocorticoids are toxic to hippocampal neurons via the activation of low-affinity glucocorticoid receptors (GRs), which triggers apoptotic death [18], and increases neuronal vulnerability to excitotoxins, reactive oxygen species and other insults [16], [15], [19][24]. However, the molecular events that mediate neuronal death in response to stress/glucocorticoids are only partially identified. We have focused on the canonical Wnt pathway, which has an established role in developmental processes, but has recently been implicated in mechanisms of neurodegeneration/neuroprotection in the adult brain [25][27]. In addition, Wnt signalling regulates the fate of adult hippocampal neural stem/progenitor cells [28], [29]. The canonical Wnt pathway controls the stability of the intracellular protein, β-catenin, which, if no degraded, translocates to the nucleus, binds to lymphoid enhancer-binding factor (LEF) and T cell factor (TCF) proteins, and acts as a transcriptional co-activator to regulate the expression of Wnt-dependent genes. In the absence of Wnt ligands, β-catenin is phosphorylated by a “degradation complex” that comprises glycogen synthase kinase 3β (GSK3β), casein kinase 1α, Axin, and adenomatous polyposis coli (APC). Phosphorylation of β-catenin leads to its ubiquitynation by a specific E3 ligase, and proteasomal degradation. Interaction of Wnt glycoproteins with 7-TM Frizzled receptors and low density lipoprotein receptor-related proteins 5/6 (LRP5/6) co-receptors inhibits the β-catenin degradation complex via the Dishevelled cytoplasmic phosphoproteins, thus enhancing the intracellular levels of β-catenin [30]. The canonical Wnt pathway is inhibited by Dickkopf-1 (Dkk-1), a member of the Dkk family of secreted Wnt antagonists [31]. Dkk-1 binds to LRP5/6 and the single-pass transmembrane proteins Kremen-1 and -2 forming a ternary complex that disrupts Wnt signalling by promoting endocytosis of LRP5/6 [32]. Induction of Dkk-1 with the ensuing inhibition of the canonical Wnt pathway has been linked to processes of neuronal death in cultures challenged with excitotoxins or β-amyloid, and in animal models of global and focal brain ischemia or temporal lobe epilepsy. In addition, expression of Dkk-1 is increased in degenerating neurons of the Alzheimer's brain and in hippocampal neurons of patients with mesial temporal lobe epilepsy associated with Ammon's horn sclerosis [33][37]. We now show that (i) acute and chronic mild restraint stress selectively enhances Dkk-1 expression in the hippocampus; (ii) the action of stress requires the integrity of the HPA axis and is mimicked by exogenous corticosterone; and (iii) mice with hypomorphic Dkk-1 alleles are protected against stress-induced hippocampal damage.

Results

1. Induction of Dkk-1 in the hippocampus of mice subjected to mild restraint stress

CD1 mice were killed 1, 3 or 7 days after a 3-h exposure to mild restraint stress. Immunoblot analysis with anti-Dkk-1 antibodies showed a band corresponding to the molecular size of Dkk-1 (35 kDa), which was prominent in the mouse liver, used as a control tissue. Dkk-1 levels were very low in the hippocampus of control mice, as expected (see representative immunoblot in Figure 1A). A single exposure to stress substantially increased Dkk-1 levels in the hippocampus after 1 and 3 days. The increase was still visible, albeit to a lesser extent, after 7 days (Figure 1A). No changes in Dkk-1 levels were seen in the cerebral cortex and hypothalamus at least at 1 day after stress (Figure 1B). In another set of experiments, mice were exposed daily to restraint stress for 21 consecutive days. This treatment led to a substantial increase in hippocampal Dkk-1 levels, which peaked in the first 3 days, and could still be detected at 7, 14, and 21 days (Figure 1D). Mice killed 3 days following a single exposure to stress were also used for immunohistochemical analysis, which showed a prominent increase in Dkk-1 immunostaining in all hippocampal subfields in response to stress. Dkk-1 immunostaining was restricted to neurons, spared the cell nucleus, and was detected both intra- and extracellularly, as expected for a secreted protein (Figure 1C). Immunohistochemical analysis was also used for the detection of β-catenin, the levels of which are critically regulated by the Wnt pathway (see Introduction and references therein). Consistent with the increase in Dkk-1 levels, acute stress induced a reduction in β-catenin immunoreactivity in the cytoplasmic and nuclear region of hippocampal pyramidal neurons (Figure 1C). This reduction could not be consistently confirmed by immunoblot analysis, perhaps because of the widespread expression of β-catenin in different cell types within the hippocampus (Figure 1C).

Figure 1
Induction of Dkk-1 in the hippocampus of CD1 mice exposed to acute or chronic restraint stress.

2. Mild restraint stress fails to increase hippocampal Dkk-1 levels in adrenalectomized mice

To examine whether the activation of the HPA axis is involved in the increase in hippocampal Dkk-1 levels associated with stress, we used CD1 mice subjected to surgical bilateral adrenalectomy, and exposed to acute mild restraint stress 7 days later. In adrenalectmized mice, hippocampal Dkk-1 levels were nearly undetectable under control conditions, and failed to increase 1 day following acute restraint stress. However, a significant increase in hippocampal Dkk-1 levels was seen when these mice were treated systemically with corticosterone (1 mg/kg, s.c.), and killed 1 day later (Figure 1E).

3. Addition of corticosterone induces Dkk-1 expression in organotypic hippocampal cultures and cultured hippocampal neurons

To examine whether Dkk-1 expression in the hippocampus could be directly induced by glucocorticoids we used two in vitro models: (i) organotypic hippocampal cultures; and (ii) primary cultures of hippocampal neurons. In organotypic hippocampal cultures, addition of corticosterone (100 nM and 1 µM) increased Dkk-1 immunoreactivity after 24 h. No increase was seen in response to 10 nM corticosterone (Figure 2A). Immunofluorescent analysis of organotypic hippocampal cultures exposed to 1 µM corticosterone showed that induction of Dkk-1 was prominent in the CA4 and CA3 subfields although it was also visible in the CA1 region and dentate gyrus (Figure 2B). We also used primary cultures of mouse and rat hippocampal neurons at 10 days in vitro (DIV). These cultures contain >95% of neurons with 2-3% of contaminating astrocytes (not shown). A single pulse with corticosterone (100 nM) substantially increased Dkk-1 levels in hippocampal neurons, as shown by immunoblot analysis (Figure 2C,D). The action of corticosterone was reversed by the type-2 glucocorticoid receptor (GR) antagonist mifepristone (10 µM), but not by the selective mineralcorticoid receptor (MR) antagonist, spironolactone (10 µM). Neither mifepristone nor spironolactone had any effect on Dkk-1 levels on their own (Figure 2C,D). These data suggest that corticosterone induces Dkk-1 expression in hippocampal neurons via the activation of low-affinity type-2 GRs.

Figure 2
Exogenous corticosterone enhances Dkk-1 expression in organotypical hippocampal slice cultures and cultured hippocampal neurons.

4. Insertional mutant mice lacking a transcriptional enhancer in the Dkk1 gene (“doubleridge” mice) are resistant to stress-induced hippocampal damage

We used mice chronically exposed to mild restraint stress to examine whether induction of Dkk-1 with the ensuing inhibition of the canonical Wnt pathway could contribute to stress-induced hippocampal damage. Stress was delivered once a day for 21 days to control C3H mice or to doubleridge mice, which show a defective expression of Dkk-1 in response to developmental cues (45), or to neuronal insults in the adult life [37], [46]. A bias inherent to the doubleridge model is that these mice show higher basal Dkk-1 protein levels in brain tissue [46], although the Dkk1 gene is not fully responsive to inductive cues. We could not use Dkk1 knockout mice because these mice die before birth [47]. We first examined the Dkk-1 response 1 day after a single exposure to mild restraint stress in doubleridge mice and their controls (C3H mice). Doubleridge mice showed higher basal Dkk-1 levels in the hippocampus, but they showed an abnormal response to stress. Exposure to stress enhanced hippocampal Dkk-1 levels in C3H control mice as expected, but reduced Dkk-1 levels in doubleridge mice. This was shown by both immunoblotting (Figure 3A) and immunohistochemistry (Figure 3B). Immunohistochemical analysis also showed that stress reduced β-catenin immunoreactivity in hippocampal pyramidal neurons of C3H mice. Remarkably, β-catenin levels were constitutively low in doubleridge mice and did not change in response to stress (Figure 3B). The paradoxical behaviour of Dkk-1 in doubleridge mice was confirmed using primary cultures of hippocampal neurons. Basal Dkk-1 levels were higher in cultures prepared from doubleridge mice than in cultures prepared from C3H control mice (Figure 3D). Addition of corticosterone (1 µM) enhanced Dkk-1 expression in C3H cultures, but reduced Dkk-1 levels in doubleridge cultures (Figure 3D).

Figure 3
Dkk-1 response to stress or corticosterone in C3H and doubleridge mice.

We then examined the Dkk-1 response to chronic stress in the hippocampus of the two strains of mice. C3H mice responded to chronic stress with a long-lasting increase in hippocampal Dkk-1 levels, which peaked in the first 3 days and persisted after 21 days. Thus, C3H mice were similar to CD1 mice in their response to stress. In contrast, in doubleridge mice, chronic stress induced an initial reduction in Dkk-1 levels, which then recovered after 1 week (Figure 3C). Using the chronic paradigm of mild restraint stress, we examined the following parameters related to hippocampal damage: (i) hippocampal volume; (ii) stereological counting of CA1 neurons; (iii) dendritic arborization in CA1 neurons; and (iv) proliferation of neuroprogenitors and neurogenesis in the hippocampal dentate gyrus. Hippocampal volume did not differ between C3H and doubleridge mice. However, a 21-day restraint stress induced a significant reduction in hippocampal volume in C3H mice, but not in doubleridge mice (Figure 4A). We carried out stereological neuronal counting in the CA1 region, where there is evidence of neuronal loss in response to stress/glucocorticoids [48]. Chronic stress caused a 23% reduction in the number of CA1 neurons in C3H mice, but did not cause any significant neuronal loss in doubleridge mice (Figure 4B). In C3H mice, chronic stress produced dendritic retraction in CA1 pyramidal neurons, as shown by measurements of dendritic length and dendritic branching (Figure 4C,D,E). Interestingly, doubleridge mice showed a reduced dendritic arborisation under basal conditions, and, paradoxically, responded to chronic stress with an increased dendritic arborisation (Figure 4D,E). Finally, we measured the effect of chronic stress on proliferation of neuroprogenitor cells and on neurogenesis in the hippocampal dentate gyrus by combining (i) quantitative dot-blot analysis of DNA-containing 5-bromo-2′deoxyuridine (BrdU) in hippocampal extracts [49]; (ii) stereological counting of BrdU-positive cells in the dentate gyrus; and (iii) stereological counting of cells expressing the early neurogenic factor, DCX [50]. In C3H mice, chronic restraint stress significantly reduced BrdU staining as well as the number of DCX-positive cells in the dentate gyrus (Figure 5A,B,C). Doubleridge mice showed a lower number of BrdU-positive cells (Figure 5B), but no changes in the number of DCX-positive cells (Figure 5C) in the dentate gyrus, as compared with C3H mice. Once again, stress produced paradoxical effects in doubleridge mice, causing an increased proliferation of neuroprogenitors, as detected by both dot-blot analysis (Figure 5A) and BrdU immunostaining (Figure 5B).

Figure 4
Chronic restraint stress causes hippocampal damage in C3H mice, but not in doubleridge mice.
Figure 5
Chronic stress reduces proliferation of neuroprogenitors and neurogenesis in the dentate gyrus of C3H mice, but enhances proliferation of neuroprogenitors in doubleridge mice.

Discussion

Our data show for the first time that glucocorticoids induce Dkk-1 in the central nervous system, and suggest that Dkk-1 induction and the ensuing inhibition of the canonical Wnt pathway is a critical component of the molecular cascade leading to hippocampal damage in response to stress. Data obtained with mifepristone in cultured hippocampal neurons suggest that glucocorticoids induce Dkk-1 expression via the activation of GRs. This is fully consistent with the evidence that an excessive activation of GRs, as occurs during prolonged exposure to stress, produces neurotoxic effects in the hippocampus, whereas activation of MRs is neuroprotective [18]. The Dkk-1 gene promoter contains at least three glucocorticoid-responsive elements (GREs), and the GR agonist, dexamethasone, enhances Dkk-1 gene expression in human osteoblasts [51]. Thus, induction of Dkk-1 by corticosterone in hippocampal neurons might be mediated by the transcriptional activity of GRs. Alternatively, Dkk-1 induction might be a by-product of the death cascade triggered by GR activation [18]. The Dkk1 gene promoter contains a p53-responsive element, and p53 enhances Dkk-1 expression [52]. In addition, a number of apoptotic agents induce Dkk-1 expression via the transcription factor, Jun [53].

Immunohistochemical data obtained in mice exposed to stress or in organotypic hippocampal cultures challenged with corticosterone indicated that Dkk-1 induction was prominent in the CA3 and CA1 hippocampal subfields, which are particularly susceptible to damage induced by stress/glucocorticoids. Accordingly, chronic restraint stress caused dendritic retraction and neuronal loss in the CA1 region (analysis was not extended to the CA3 region). Although stress-induced dendritic atrophy is more often detected in the CA3 region [9][11], [13], [14], [54], it also occurs in CA1 neurons [55], where changes in synaptic organization are also observed [56]. All these changes render hippocampal neurons more vulnerable to excitotoxins and other insults (see Introduction and references therein). To examine the relationship between Dkk-1 induction and hippocampal damage, we used transgenic homozygous mice expressing an insertional mutant Dkk1 (doubleridge) alleles lacking a transcriptional enhancer. We could not use Dkk1-null mice because they die perinatally due to an incomplete development of structures anterior to the midbrain [47]. In doubleridge mice, a transgene insertion in chromosome 19 causes a defective Dkk-1 induction [45], [57], which we have confirmed both in vitro and in vivo. Unexpectedly, doubleridge mice showed higher basal hippocampal Dkk-1 levels associated with dendritic abnormalities in hippocampal neurons as compared to age-matched controls. Thus, perhaps because of the constitutively high expression levels of Dkk-1, doubleridge mice showed some phenotypic features shared by wild-type mice exposed to chronic stress. Interestingly, doubleridge mice showed a paradoxical response to stress, which caused a reduction and not an increase in Dkk-1 levels in hippocampal neurons. In nice agreement with these findings, addition of corticosterone to cultured hippocampal neurons prepared from doubleridge mice reduced and did not increase Dkk-1 levels. Chronic stress did not cause any hippocampal damage in doubleridge mice, which instead responded to stress with a dendritic remodelling similar to that observed in normal mice during the recovery phase after stress. These data suggest that stress-induced hippocampal damage is causally related to the in Dkk-1 expression (and the inhibition of the Wnt pathway), and that under conditions in which Dkk-1 is reduced rather than increased (i.e. in doubleridge mice), chronic stress may have beneficial effects on hippocampal morphology. However, the relationship between Dkk-1 and stress-induced neuronal damage deserves some comments because acute stress did not cause hippocampal damage in control mice in spite of the robust induction of Dkk-1. It is possible that Dkk-1 may be necessary but not sufficient as a death messenger, and other events induced by chronic stress, such as the reduction of brain-derived neurotrophic factor [1], enable the development of hippocampal damage. We also used doubleridge mice to examine whether induction of Dkk-1 was instrumental for the reduction of hippocampal neurogenesis associated with chronic stress. Activation of the canonical Wnt pathway supports self-renewal and neuronal fate commitment of neural stem/progenitor cells of the adult hippocampal dentate gyrus [28], [58][60]. The regulation of adult neurogenesis by Dkk-1 has never been studied. Using the HB1.F3 line of immortalized neural stem cells, Ahn et al. [61] have found that olig2-induced cell differentiation into astrocytes, oligodendrocytes, and neurons required the induction of Dkk-1 and the resulting inhibition of the canonical Wnt pathway. In C3H mice, chronic stress reduced BrdU incorporation in hippocampal neuroprogenitors, as well as the number of cells expressing DCX, an early marker of neuronal development in the adult hippocampus that is expressed by type-2b progenitor cells up to the stage of immature granule cells [50]. Doubleridge mice showed a reduced BrdU incorporation into hippocampal neuroprogenitors, which, again, might reflect the elevated basal Dkk-1 levels found in the hippocampus of these mice. Interestingly, chronic stress enhanced BrdU incorporation in doubleridge mice, an effect commonly seen with antidepressants in experimental animals and humans [60], [62][64]. However, it should be highlighted that the relationship between the mood-improving action of antidepressants and the increase in hippocampal neurogenesis is still matter of debate [65], [66].

We conclude that a strong relation exists between Dkk-1 induction and hippocampal damage in response to stress. This suggests that drugs that rescue the canonical Wnt pathway may be effective in preventing hippocampal damage associated with stress-related disorders, including major depression. Lithium ions and valproate activate the Wnt pathway acting as weak inhibitors of GSK3β [67], [68]. Interestingly, lithium ions are known to prevent dendritic abnormalities in the hippocampus and amygdala [69], [70], and to reverse the reduction in the proliferation of adult dentate-gyrus derived neural precursor cells induced by glucocorticoids [71]. However, lithium ions and valproate have multiple mechanisms of action and their use is limited by serious adverse effects. Dkk-1 antagonists or selective GSK3β inhibitors may be better candidates as neuroprotective agents in stress-related disorders. Finally, data shown in doubleridge mice raise the intriguing possibility that chronic stress may produce positive effects on hippocampal neuroplasticity in the presence of agents that limit Dkk-1 induction or rescue the Wnt pathway. This attractive hypothesis warrants further investigation.

Materials and Methods

In vivo experiments

Animals and treatments

Experiments were performed following the Guidelines for Animal Care and Use of the National Institutes of Health. The study was approved by Italian Ministry of Health (permit number 432007/A).

Male CD1 mice, C3H mice (Charles River, Calco, Italy) or mutant mice homozygous for an insertional mutant allele of Dkk1 gene lacking a transcriptional enhancer (doubleridge mice) (kindly provided by Miriam H. Meisler, Ann Arbor, University of Michigan, USA), 10 week-old, weighing 22–24 g were used. All mice were kept under environmentally controlled conditions (room temperature  = 22°C, humidity  = 40%) on a 12-h light/dark cycle with food and water ad libitum. For the induction of restraint stress, mice were placed for 3 h in plexiglas restrainers (length: 5 cm; width: 5 cm). The restraint device contained a 0.4 cm air hole and allowed mice to stretch their legs but not to move within the tube. Experimental manipulations were performed between 9.30 and 11.30 a.m. Mice were subjected either to single or repeated restraint stress. In the latter case, mice were placed in the restrainers 3 h per day for 21 consecutive days. Mice subjected to acute stress were killed 1, 3 or 7 days after stress. Mice subjected to chronic stress were killed 24 h after the last restraint episode at days 1, 3, 7, 14 and 21. Some groups of CD1 mice that had not been exposed to stress received an acute s.c. injection of corticosterone (1 mg/kg) dissolved in 30% DMSO/70% saline. Control mice received an equal volume of vehicle. All mice were handled gently for 5 consecutive days prior to the injections to minimize stress associated with injections. Mice were killed 24 h after injection. Additional groups of CD1 mice were adrenalectomized under pentobarbital anaesthesia, as described [38]. After surgery, all animals were given free access to 0.9% NaCl in addition to normal drinking water. Adrenalectomized mice were subjected to an acute s.c. injection of corticosterone (1 mg/kg) dissolved in 30% DMSO/70% saline or to an acute episode of restraint stress as described above, and killed 24 h later.

Dot-blot analysis of BrdU incorporation

Mice were injected with BrdU (Sigma; 3 i.p. injections of 50 mg/kg, with 2 h of interval, cumulative dose: 150 mg/kg,) and killed 24 h later. Mice were anesthetized with chloralium hydrate (320 mg/kg, i.p.), and perfused with 30 ml of saline. Hippocampi were dissected, minced quickly with a razor blade, and frozen at 80°C. Genomic DNA was extracted from hippocampal tissues by a DNA isolation buffer (50 mM Tris HCl, pH 8.0, 100 mM NaCl, 100 mM EDTA, 1% SDS, 1 mg/ml proteinase K) overnight at 56°C. Genomic DNA was precipitated by centrifugation at 13,000 g, washed twice with 100% ethanol, and suspended in Tris-EDTA buffer (10 mM Tris HCl, pH 8.0, 1 mM EDTA). To eliminate RNA, the DNA samples were incubated for 1 h at 37°C with ribonuclease A (33 µg/ml, Sigma). Purified DNA was quantitated by spectrophotometry and 50 µl were single stranded by incubation with 10 µl of 0.4 N NaOH for 30 min at room temperature and kept on ice to prevent annealing. The DNA solution was placed on ice and neutralized by an equal volume of 1 M Tris HCl (pH 6.8). The single-stranded neutralized DNA (50 ng/5 µl) was dot-blotted onto a nitrocellulose membrane (Bio-Rad, Hercules, CA).

To visualize the BrdU signal, membranes were incubated with mouse anti-BrdU monoclonal antibodies (1[ratio]100, Becton Dickinson) in a buffer containing 20 mM Tris HCl, pH 7.6, 136 mM NaCl, and 0.05% Tween 20 (TBS-T) containing 1% non-fat milk overnight at 4°C. After being washed with TBS-T, membranes were incubated with a horseradish peroxidase-conjugated anti-mouse IgG antibody (1[ratio]5,000; EMD Biosciences) for 1 h at room temperature. Membranes were washed with TBS-T, analyzed by enhanced chemiluminescence (GE Helthcare), and exposed to autoradiography film (Daigger, Vernon Hills, IL). Intensity of each BrdU signal was quantitated by densitometric analysis using Kodak one-dimensional software.

Immunohistochemistry and Nissl staining

Mice were anesthetized with chloralium hydrate (320 mg/kg, i.p.) and transcardially perfused with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer, pH 8. Brains were removed, post-fixed overnight in 4% PFA, and then transferred in 30% sucrose for cryoprotection. Serial 30 µm coronal sections were obtained from the whole rostrocaudal extent of the hippocampus and processed for Dkk-1 and β-catenin immunostaining using the following primary antibodies: goat polyclonal Dkk-1 (1[ratio]10; R&D System Inc., Minneapolis, MN) and rabbit polyclonal anti-β-catenin (1[ratio]10; Santa Cruz Biotechnology Inc., Santa Cruz, CA); sections were then exposed for 1 h to secondary biotinylated anti-goat or anti-rabbit antibodies (1[ratio]200; Vector Laboratories, Burlingame, CA). 3,3-Diaminobenzidine tetrachloride was used for detection (ABC Elite kit; Vector Laboratories). Control staining was performed without the primary antibodies.

For (i) immunohistochemical analysis of cells expressing BrdU (in mice injected with BrdU - see above -), (ii) immunohistochemical analysis of cells expressing doublecortin (DCX), and (iii) histological analysis, brains were fixed in Carnoi (ethanol:acetic acid:chloroform, 6[ratio]1[ratio]3), embedded in paraffin and sectioned at 30 µm. Deparaffinized sections were soaked in 3% hydrogen peroxide to block endogenous peroxidase activity. Sections were treated with 10 mM, pH 6.0, citrate buffer, and heated in a microwave for 10 min for antigen retrieval. The slides were allowed to cool for 20 min in the same solution at room temperature and then washed in TBS. The sections were incubated overnight with mouse monoclonal anti-BrdU (1[ratio]20, Becton Dickinson) or rabbit polyclonal anti-DCX (1[ratio]50, Santa Cruz Biotechnology Inc.), and then for 1 h with secondary biotinylated anti-mouse or anti-rabbit antibodies (1[ratio]200; Vector Laboratories, Burlingame, CA). 3,3-Diaminobenzidine tetrachloride was used for detection (ABC Elite kit; Vector Laboratories). Control staining was performed without the primary antibodies.

Deparaffinized sections were also processed for staining with thionin (Nissl staining). After rinses in dH2O, sections were incubated for 8 min in thionin. The number of surviving neurons in the pyramidal cell layer was counted by a stereological method (see below). The mean hippocampal volume was determined by quantitative light microscopical methods using the Cavalieri's method [39], [40]. Rostrocaudal sections from the entire hippocampus of each animal were taken every 150 µm and the volume was calculated by using the following formula: V = Σ(A)i*TS*n where Ai is the area measured outlining the regions of interest on section ith at 2.5× magnification, TS the section thickness (30 µm), and n the number of sections through the levels.

Stereological counting

Stereological cell counting was performed using the ImagePro Plus 6.2 software coupled to a Axio Imager M1 microscope. The optical fractionator technique (adapted to 30 µm thick sections) was used to obtain estimates of total cells numbers within the hippocampus [41], [42]. A systematically sampled series of sections every 150 µm spanning the entire extent of the hippocampus was selected for quantification. The number of BrdU or DCX-positive cells was quantified on both hippocampi (n = 5 mice for each experimental group). During quantification, the regions of interest were outlined on the section at 2.5× magnification. After outlining the regions of interest, a sampling grid of known dimensions (75×75 µm) was positioned over each area and counting was carried out using a 100X oil immersion lens [43].

Assessment of dendritic arborisation in hippocampal pyramidal cells

Mice were anesthetized with chloralium hydrate (320 mg/kg, i.p.) and transcardially perfused with 4% PFA in 0.1 M phosphate buffer, pH 7.4. Brains were removed, post-fixed overnight in 4% PFA, and then transferred in 30% sucrose for cryoprotection. Brains were quickly frozen in 2-methylbutane, and processed according to the commercial rapid Golgi staining kit (FD Neurotechnologies Consulting & Services, Ellicott City, MD). In brief, whole brains were treated for silver impregnation for 2 weeks. Sixty µm brain sections, obtained on a cryostat, were stained and mounted in resinous medium. Dendritic length and branch points (number of dendritic bifurcations) were quantified using the ImagePro Plus 6.2 software coupled to an Axio Imager M1 microscope. Briefly, this equipment allows to perform a 3 dimensional reconstruction of the neuron by merging images acquired on different focal planes (every 5 µm). We superimposed a manual line from the neuronal soma up to the single dendrite tip.

In vitro experiments

Organotypic hippocampal slice cultures

Postnatal day 6–7 (P6/7) mouse organotypic hippocampal slice cultures were prepared as described previously [44]. Briefly, hippocampi were dissected in ice-cold dissecting medium (50% Minimal Essential Media (MEM) with no bicarbonate, 50% calcium and magnesium-free Hank's Balanced Salt Solution (HBSS), 7.5 mM D-glucose, 20 mM HEPES, pH 7.15). Hippocampi were isolated and then sectioned coronally at 300 µm thickness with a mechanical tissue chopper. The slices were separated and transferred to sterile, porous membrane units (0.4 µm, Millicell-CM, Millipore, Temecula, CA), five per insert, containing 1 ml of culturing medium in each dish (50% MEM with Earle's salt and L-glutamine, 25% HBSS, 25% horse serum with 6.5 mg/L D-glucose, 20 mM HEPES and 50 U/ml streptomycin-penicillin). Culture medium was replaced every 2 days, and slices were kept at 37°C in 5% CO2 for 9 days before experiments. Corticosterone (10 nM, 100 nM or 1 µM) was applied for 24 h. At the end of treatment, slices were fixed in 4% PFA. After rinsing, slice were blocked with 5% normal goat serum diluted in PBS with 1% Triton X-100 for 2 h. Slices were incubated overnight with the primary goat polyclonal anti-Dkk-1 antibody (1[ratio]10; R&D System). After rinsing, slices were incubated with a secondary biotinylated anti-goat (1[ratio]200; Vector Laboratories, Burlingame, CA). 3,3-Diaminobenzidine tetrachloride was used for detection (ABC Elite kit; Vector Laboratories). Alternatively, fluorescence immunohistochemistry was performed incubating brain slices overnight with goat polyclonal anti-Dkk-1 (1[ratio]10; R&D System) and then for 5 min with propidium iodide (1[ratio]10).

Preparation of primary cultures of hippocampal neurons

Cultured neurons were prepared from the hippocampus of E14-16 C3H and doubleridge mice. In brief, dissected hippocampi were triturated with a fire-polished Pasteur pipette to dissociate the tissue into single cells. After centrifugation (1,000 g, 7 min), the cell pellet was resuspended in Neurobasal Medium supplemented with B27, and 500 μM L-glutamine and plated at a density of 4×105 to 7×105 cells/ml in culture dishes coated with poly-D-lysine (molecular weight 70,000–150,000, 0.1 mg/ml; Sigma, St. Louis, MO).

Cultured neurons were also prepared from the hippocampus of Sprague-Dawley rat pups (P1-P2) (Charles River). Briefly, hippocampi were dissected in Ca2+/Mg2+ free buffer and mechanically dissociated. Dissected hippocampi were then triturated with a fire-polished Pasteur pipette to dissociate the tissue into single cells. After centrifugation (1,500 g, 6 min), the cell pellet was resuspended in Neurobasal Medium supplemented with B27, and 500 μM L-glutamine and plated at a density of 4×105 to 7×105 cells/ml in culture dishes precoated with 0.1 mg/ml poly-D-lysine.

All cultures were grown in a humidified atmosphere containing 5% CO2 at 37°C. At 10 DIV, cultures were incubated with corticosterone (0.01–1 µM for 16–24 h) in the presence or absence of spironolactone (10 µM) and mifepristone (10 µM); afterwards, cells were washed three times with ice-cold PBS and lysed with lysis buffer (20 mM Tris, 1 mM EDTA, 1% Triton X-100, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 1 µg/ml aprotinin, 1 µg/ml pepstatin and 1 µg/ml leupeptin) for 15 min and used for Western blot analysis.

Western blot analysis

Western blot analysis of Dkk-1 was performed in protein extracts of primary hippocampal cultures or in protein lysates obtained from mouse brain regions. Blots were incubated overnight at 4°C with the goat polyclonal Dkk-1 primary antibody (2 µg/ml, R&D System). Blots for mouse monoclonal β-actin (Sigma) were incubated for 1 h at room temperature (1[ratio]60,000). Filters were washed three times with TTBS buffer (100 mM Tris-HCl, 0.9% NaCl, and 0.1% Tween 20, pH 7.4) and then incubated for 1 h with secondary peroxidase-coupled antibodies (anti-goat 1[ratio]2,000 or anti-mouse, 1[ratio]7,000; EMD Biosciences, Darmstadt, Germany). Immunostaining was revealed by enhanced-chemiluminescence luminosity (GE Healthcare, Buckingamshire, UK).

Acknowledgments

We wish to thank Prof. Miriam H. Meisler, University of Michigan, Ann Arbor, MI, for kindly providing transgenic doubleridge mice.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: Support was provided by institutional funds (Ricerca Corrente 2009-2010 from the Italian Ministry of Health to Istituto Neurologico Mediterraneo Neuromed, Pozzilli; Istituto C. Mondino, Pavia; and Istituto San Raffaele Pisana, Roma). Salaries to university people are from university funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455:894–902. [PMC free article] [PubMed]
2. Brouwer JP, Appelhof BC, Hoogendijk WJ, Huyser J, Endert E, et al. Thyroid and adrenal axis in major depression: a controlled study in outpatients. Eur J Endocrinol. 2005;152:185–191. [PubMed]
3. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry. 2004;55:1–9. [PubMed]
4. Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav. 2003;43:60–66. [PubMed]
5. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57:925–935. [PubMed]
6. Sapolsky RM. Depression, antidepressants, and the shrinking hippocampus. Proc Natl Acad Sci U S A. 2001;23:12320–12322. [PMC free article] [PubMed]
7. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003;160:1516–1518. [PubMed]
8. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci. 1990;10:2897–2902. [PubMed]
9. Watanabe Y, Gould E, Cameron HA, Daniels DC, McEwen BS. Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus. 1992;2:431–435. [PubMed]
10. Watanabe Y, Gould E, McEwen BS. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res. 1992;588:341–345. [PubMed]
11. Magariños AM, McEwen BS. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience. 1995;69:83–88. [PubMed]
12. Kleen JK, Sitomer MT, Killeen PR, Conrad CD. Chronic stress impairs spatial memory and motivation for reward without disrupting motor ability and motivation to explore. Behav Neurosci. 2006;120:842–851. [PMC free article] [PubMed]
13. Conrad CD, McLaughlin KJ, Harman JS, Foltz C, Wieczorek L, et al. Chronic glucocorticoids increase hippocampal vulnerability to neurotoxicity under conditions that produce CA3 dendritic retraction but fail to impair spatial recognition memory. J Neurosci. 2007;27:8278–8285. [PMC free article] [PubMed]
14. McLaughlin KJ, Gomez JL, Baran SE, Conrad CD. The effects of chronic stress on hippocampal morphology and function: an evaluation of chronic restraint paradigms. Brain Res. 2007;1161:56–64. [PMC free article] [PubMed]
15. Sapolsky RM. Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J Neurosci. 1986;6:2240–2244. [PubMed]
16. Sapolsky RM, Krey LC, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci. 1995;5:1222–1227. [PubMed]
17. Uno H, Tarara R, Else JG, Suleman MA, Sapolsky RM. Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci. 1989;9:1705–1711. [PubMed]
18. Crochemore C, Lu J, Wu Y, Liposits Z, Sousa N, et al. Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry. 2005;10:790–798. [PubMed]
19. Armanini MP, Hutchins C, Stein BA, Sapolsky RM. Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent. Brain Res. 1990;532:7–12. [PubMed]
20. Elliott EM, Mattson MP, Vanderklish P, Lynch G, Chang I, et al. Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J Neurochem. 1993;61:57–67. [PubMed]
21. Lawrence MS, Sapolsky RM. Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons. Brain Res. 1994;646:303–306. [PubMed]
22. Adachi N, Chen J, Liu K, Tsubota S, Arai T. Dexamethasone aggravates ischemia-induced neuronal damage by facilitating the onset of anoxic depolarization and the increase in the intracellular Ca2+ concentration in gerbil hippocampus. J Cereb Blood Flow Metab. 1998;18:274–280. [PubMed]
23. Yusim A, Ajilore O, Bliss T, Sapolsky R. Glucocorticoids exacerbate insult-induced declines in metabolism in selectively vulnerable hippocampal cell fields. Brain Res. 2000;870:109–117. [PubMed]
24. Roy M, Sapolsky RM. The exacerbation of hippocampal excitotoxicity by glucocorticoids is not mediated by apoptosis. Neuroendocrinology. 2003;77:24–31. [PubMed]
25. Caricasole A, Copani A, Caruso A, Caraci F, Iacovelli L, et al. The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease? Trends Pharmacol Sci. 2003;24:233–238. [PubMed]
26. De Ferrari GV, Moon RT. The ups and downs of Wnt signaling in prevalent neurological disorders. Oncogene. 2006;25:7545–7553. [PubMed]
27. Caraci F, Busceti C, Biagioni F, Aronica E, Mastroiacovo F, et al. The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders. Neurochem Res. 2008;33:2401–2416. [PubMed]
28. Lie DC, Colamarino SA, Song HJ, Désiré L, Mira H, et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature. 2005;437:1370–1375. [PubMed]
29. Wexler EM, Geschwind DH, Palmer TD. Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry. 2008;13:285–292. [PubMed]
30. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004;5:691–701. [PubMed]
31. Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci. 2003;116:2627–2634. [PubMed]
32. Mao B, Wu W, Davidson G, Marhold J, Li M, et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature. 2002;417:664–667. [PubMed]
33. Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, et al. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J Neurosci. 2004;24:6021–6027. [PubMed]
34. Cappuccio I, Calderone A, Busceti CL, Biagioni F, Pontarelli F, et al. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death. J Neurosci. 2005;25:2647–2657. [PubMed]
35. Scali C, Caraci F, Gianfriddo M, Diodato E, Roncarati R, et al. Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1. Neurobiol Dis. 2006;24:254–265. [PubMed]
36. Busceti CL, Biagioni F, Aronica E, Riozzi B, Storto M, et al. Induction of the Wnt inhibitor, Dickkopf-1, is associated with neurodegeneration related to temporal lobe epilepsy. Epilepsia. 2007;48:694–705. [PubMed]
37. Mastroiacovo F, Busceti CL, Biagioni F, Aronica E, Riozzi B, et al. Induction of the Wnt antagonist, Dickkopf-1, contributes to the development of neuronal death in models of brain focal ischemia. J Cereb Blood Flow Metab. 2009;29:264–276. [PubMed]
38. de Jong IE, Oitzl MS, de Kloet ER. Adrenalectomy prevents behavioural sensitisation of mice to cocaine in a genotype-dependent manner. Behav Brain Res. 2007;177:329–339. [PubMed]
39. Stuart DA, Oorschot DE. Embedding, sectioning, immunocytochemical and stereological methods that optimize research on the lesioned adult rat spinal cord. J Neurosci Methods. 1995;61:5–14. [PubMed]
40. Pakkenberg B, Gundersen HJ. Neocortical neuron number in humans: effect of sex and age. J Comp Neurol. 1997;384:312–320. [PubMed]
41. West MJ, Slomianka L, Gundersen HJG. Unbiased stereological estimation of the total number of neurons in the subdivisions of rat hippocampus using the optical fractionator. Anat Rec. 1991;231:482–497. [PubMed]
42. Gundersen HJG, Jensen EBV, Kiêu K, Nielsen J. The efficiency of systematic sampling in stereology-reconsidered. J Microsc. 1999;193:199–211. [PubMed]
43. King MA, Scotty N, Klein RL, Meyer EM. Particle detection, number estimation and feature measurement in gene transfer studies: optical fractionator stereology integrated with digital image processing and analysis. Methods. 2002;28:293–299. [PubMed]
44. Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods. 1991;37:173–182. [PubMed]
45. Adamska M, MacDonald BT, Meisler MH. Doubleridge, a mouse mutant with defective compaction of the apical ectodermal ridge and normal dorsal-ventral patterning of the limb. Dev Biol. 2003;255:350–362. [PubMed]
46. Busceti CL, Biagioni F, Riozzi B, Battaglia G, Storto M, et al. Enhanced tau phosphorylation in the hippocampus of mice treated with 3,4-methylenedioxymethamphetamine (“Ecstasy”). J Neurosci. 2008;28:3234–3245. [PubMed]
47. Mukhopadhyay M, Shtrom S, Rodriguez-Esteban C, Chen L, Tsukui T, et al. Dickkopf1 Is Required for Embryonic Head Induction and Limb Morphogenesis in the Mouse. Dev Cell. 2001;1:423–434. [PubMed]
48. Haynes LE, Griffiths MR, Hyde RE, Barber DJ, Mitchell IJ. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: implications for mood disorders. Neuroscience. 2001;104:57–69. [PubMed]
49. Ueda J, Saito H, Watanabe H, Evers BM. Novel and quantitative DNA dot-blotting method for assessment of in vivo proliferation. Am J Physiol Gastrointest Liver Physiol. 2005;288:G842–847. [PubMed]
50. Kempermann G, Jessberger S, Steiner B, Kronenberg G. Milestones of neuronal development in the adult hippocampus. Trends Neurosci. 2004;27:447–452. [PubMed]
51. Ohnaka K, Taniguchi H, Kawate H, Nawata H, Takayanagi R. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun. 2004;318:259–264. [PubMed]
52. Wang J, Shou J, Chen X. Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53. Oncogene. 2000;19:1843–1848. [PubMed]
53. Grotewold L, Rüther U. The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death. EMBO J. 2002;21:966–975. [PMC free article] [PubMed]
54. Woolley CS, Gould E, McEwen BS. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 1990;531:225–231. [PubMed]
55. Morales-Medina JC, Sanchez F, Flores G, Dumont Y, Quirion R. Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat. J Chem Neuroanat. 2009;38:266–272. [PubMed]
56. Donohue HS, Gabbott PL, Davies HA, Rodríguez JJ, Cordero MI, et al. Chronic restraint stress induces changes in synapse morphology in stratum lacunosum-moleculare CA1 rat hippocampus: a stereological and three-dimensional ultrastructural study. Neuroscience. 2006;140:597–606. [PubMed]
57. MacDonald BT, Adamska M, Meisler MH. Hypomorphic expression of Dkk1 in the doubleridge mouse: dose dependence and compensatory interactions with Lrp6. Development. 2004;131:2543–2552. [PubMed]
58. Michaelidis TM, Lie DC. Wnt signaling and neural stem cells: caught in the Wnt web. Cell Tissue Res. 2008;331:193–210. [PubMed]
59. Kalani MY, Cheshier SH, Cord BJ, Bababeygy SR, Vogel H, et al. Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci U S A. 2008;105:16970–16975. [PMC free article] [PubMed]
60. Wexler EM, Paucer A, Kornblum HI, Plamer TD, Geschwind DH. Endogenous Wnt signaling maintains neural progenitor cell potency. Stem Cells. 2009;27:1130–1141. [PMC free article] [PubMed]
61. Ahn SM, Byun K, Kim D, Lee K, Yoo JS, et al. Olig2-induced neural stem cell differentiation involves downregulation of Wnt signaling and induction of Dickkopf-1 expression. PLoS One. 2008;3:e3917. [PMC free article] [PubMed]
62. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000;20:9104–9110. [PubMed]
63. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301:805–809. [PubMed]
64. Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, et al. Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology. 2009;34:2376–2389. [PMC free article] [PubMed]
65. Huang GJ, Bannerman D, Flint J. Chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice. Mol Psychiatry. 2008;13:119–121. [PubMed]
66. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry. 2009;14:764–773. [PubMed]
67. Lenox RH, Hahn CG. Overview of the mechanism of action of lithium in the brain: fifty-year update. J Clin Psychiatry. 2000;61:5–15. [PubMed]
68. Jope RS, Bijur GN. Mood stabilizers, glycogen synthase kinase-3beta and cell survival. Mol Psychiatry. 2002;7:S35–45. [PubMed]
69. Johnson SA, Wang J-F, Sun X, McEwen BS, Chattarji S, et al. Lithium treatment prevents stress-induced dendritic remodeling in the rodent amygdala. Neuroscience. 2009;163:34–39. [PubMed]
70. Boku S, Nakagawa S, Masuda T, Nishikawa H, Kato A, et al. Glucocorticoids and lithium reciprocally regulate the proliferation of adult dentate gyrus-derived neural precursor cells through GSK-3β and β-catenin/TCF pathway. Neuropsychopharmacol. 2009;34:805–815. [PubMed]
71. Wood GE, Young LT, Reagan LP, Chen B, McEwen BS. Stress-induced structural remodelling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci U S A. 2004;101:3973–3978. [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...